YKL-40 and P53 expressions in anal carcinoma predict shorter overall and disease free survival

MLA

Mistrangelo, M., et al. YKL-40 and P53 Expressions in Anal Carcinoma Predict Shorter Overall and Disease Free Survival. Jan. 2009. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od.......970..636884b4022d576257ff41caaae600ed&authtype=sso&custid=ns315887.

APA

Mistrangelo, M., Castellano, I., Cassoni, P., Crudo, V., Chiusa, L., Lupo, R., Ricardi, U., Milanesi, E., Racca, P., Beltramo, G., Mussa, A., & Morino, M. (2009). YKL-40 and P53 expressions in anal carcinoma predict shorter overall and disease free survival.

Chicago

Mistrangelo, M., Isabella Castellano, Paola Cassoni, V. Crudo, L. Chiusa, R. Lupo, Umberto Ricardi, et al. 2009. “YKL-40 and P53 Expressions in Anal Carcinoma Predict Shorter Overall and Disease Free Survival,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od.......970..636884b4022d576257ff41caaae600ed&authtype=sso&custid=ns315887.